Filing Flows

Filing Flows › Prestige Consumer Healthcare (PBH) › Next earnings date

Prestige Consumer Healthcare (PBH) earnings: beat the estimate

Prestige Consumer Healthcare (PBH) reported on Nov 5, 2026 and beat the EPS estimate: $1.13 against $1.07 (+5.3%). Revenue was $336M for Q2 FY27, +23% year over year. It beat the EPS estimate in 40% of the quarters on record.

Last result+5.3% vs estimate
Beat rate40%

The last report

Prestige Consumer Healthcare reported revenue of $336M for the second quarter fiscal 2027 (+23% Y/Y), net earnings $25.3M: Gastrointestinal $63.1M, Women's Health $53.6M, Wellness, Sleep & Other $47.3M, Dermatologicals $43.9M. How it makes money → · Every quarter →

Prestige Consumer Healthcare: EPS against the estimate, last 5 reportsPrestige Consumer Healthcare: EPS against the estimate, last 5 reportsEstimateReported$0.97$0.86Nov 25$1.16$1.14Feb 26$1.39$1.23May 26$0.88$0.98Aug 26$1.07$1.13Nov 26
Latest (Nov 26): Estimate $1.07, Reported $1.13.
PBH: the stock's move on each reportPBH: the stock's move on each reportAug 6, 2026+3.5%May 13, 2026-8.9%Feb 5, 2026-1.0%Nov 6, 2025+0.2%

Prestige Consumer Healthcare's latest quarter

Prestige Consumer Healthcare, Q2 FY27: revenue $336M (+23% year over year), operating margin 24.0%, net earnings $25.3M, operating cash flow $37.9M. The chart follows the revenue to costs, profit and cash.

Questions

Did Prestige Consumer Healthcare beat earnings?

Prestige Consumer Healthcare (PBH) reported on Nov 5, 2026 and beat the EPS estimate: $1.13 against $1.07 (+5.3%).

When does PBH report earnings?

The next date is not set yet.

Does Prestige Consumer Healthcare usually beat earnings?

It beat the consensus EPS estimate in 40% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.